Concomitant and successive amplifications of MYC in APL-like leukemia

Cancer Genetics and Cytogenetics

Volumn 197, Issue 1, 2010, Pages 75-80

  Bruyère, Hélène ^a   Sutherland, Heather ^b   Chipperfield, Katherine ^a   Hudoba, Monika ^a  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DAUNORUBICIN; HYDROXYUREA; MYC PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BLAST CELL; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CASE REPORT; CELL INCLUSION; CHROMOSOME 9; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 15; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DELETION; GENE REARRANGEMENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; THROMBOCYTE COUNT;

GENE AMPLIFICATION; GENE REARRANGEMENT; GENES, MYC; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; RECEPTORS, RETINOIC ACID;

EID: 74949095432     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.11.001     Document Type: Article

References (23)

1. Therman E., and Susman M. Human chromosomes structure, behavior, and effects. 3rd edition (1993), Springer-Verlag, New York pp. 302-9
2. Gebhart E. Double minutes, cytogenetic equivalents of gene amplification, in human neoplasia - a review. Clin Transl Oncol 7 (2005) 477-485
3. Thomas L., Stamberg J., Gojo I., Ning Y., and Rapaport A.P. Double minute chromosomes in monoblastic (M5) and myeloblastic (M2) acute myeloid leukaemia: two case reports and a review of the literature. Am J Hematol 77 (2004) 55-61
4. Receveur A., Ong J., Merlin L., Azgui Z., Merle-Béral H., Berger R., and Nguyen-Khac F. Trisomy 4 associated with double minute chromosomes and MYC amplification in acute myeloblastic leukemia. Ann Genet 47 (2004) 423-427
5. Christacos N.C., Sherman L., Roy A., DeAngelo D.J., and Dal Cin P. Is the cryptic interstitial deletion of 8q24 surrounding MYC a common mechanism in the formation of double minutes chromosome?. Cancer Genet Cytogenet 161 (2005) 90-92
6. Frater J.L., Hoover R.G., Bernreuter K., and Batanian J.R. Deletion of MYC and presence of double minutes with MYC amplification in a morphologic acute promyelocytic leukemia-like case lacking RARA rearrangement: could early exclusion of double-minute chromosomes be a prognostic factor?. Cancer Genet Cytogenet 166 (2006) 139-145
7. Grimaldi B, Davis S, Zhang Y, Lozanski G, Klisovic R, Blum W, Marcucci G, Breidenbach H, Heerema NA. Double minutes identified as amplification of the MYC oncogene in AML with APL-like morphology without RARA rearrangement. Association of Genetic Technologists 32nd Annual Meeting (Denver, CO), May 31-June 3, 2007;69:266 9(Abstract).
8. Villa O., Salido M., Pérez-Vila M.E., Ferrer A., Arenillas L., Pedro C., Espinet B., Corzo C., Serrano S., Woessner S., Florensa L., and Solé F. Blast cells with nuclear extrusions in the form of micronuclei are associated with MYC amplification in acute myeloid leukemia. Cancer Genet Cytogenet 185 (2008) 32-36
9. Kamath A., Tara H., Xiang B., Bajaj R., He W., and Li P. Double-minute MYC amplification and deletion of MTAP, CDKN2A, CDKN2B, and ELAVL2 in an acute myeloid leukemia characterized by oligonucleotide-array comparative genomic hybridization. Cancer Genet Cytogenet 183 (2008) 117-120
10. Bae S.Y., Kim J.S., Han E.A., Lim C.S., Ryeu B.J., Lee K.N., Yoon S.Y., Cho Y., Kim Y.K., and Lee C.K. Concurrent MYC and MLL amplification on dmin and hsr in acute myeloid leukemia. Leuk Lymphoma 49 (2008) 1823-1825
11. Mohammed A.N., Macoska J.A., and Kallioniemi A. Extrachromosomal gene amplification in acute myeloid leukemia: characterization by metaphase analysis, comparative genomic hybridization and semiquantitative PCR. Genes Chromosomes Cancer 8 (1993) 185-189
12. Brunel C., Sainty D., Carbuccia N., Arnoulet C., Costello R., Mozziconacci M.-J., Simonetti J., Coignet L., Gabert J., Stoppa A.-M., Birg F., and Lafage-Pochitaloff M. Unbalanced translocation t(15;17) in an atypical promyelocytic leukemia. Genes Chromosomes Cancer 14 (1995) 307-312
13. Storlazzi C.T., Fioretos T., Surace C., Lonoce A., Mastrorilli A., Strömbeck B., D'Addabbo P., Iacovelli F., Minervini C., Aventin A., Dastugue N., Fonatsch C., Hagemeijer A., Jotterand M., Mühlematter D., Lafage-Pochitaloff M., Nguyen-Khac F., Schoch C., Slovak M.L., Smith A., Solè F., Van Roy N., Johansson B., and Rocchi M. MYC-containing double minutes in hematologic malignancies: evidence in favor of the episome model and exclusion of MYC as the target gene. Hum Mol Genet 15 15 (2006) 933-942
14. Grimwade D., Walker H., Oliver F., Wheatley K., Harrison C., Harrison G., Rees J., Hann I., Stevens R., Burnett A.K., and Goldstone A.H. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 92 (1998) 2322-2333
15. Grimwade D., Walker H., Harrison G., Oliver F., Chatters S., Harrison C.J., Wheatley K., Burnett A.K., and Goldstone A.H. Medical Research Council Adult Leukemia Working Party. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood 98 (2001) 1312-1320
16. Byrd J.C., Mrozek K., Dodge R.K., Carroll A.J., Edwards C.G., Arthur D.C., Penttenati M.J., Patil S.R., Rao K.W., Watson M.S., Koduru P.R., Moore J.O., Stone R.M., Mayer R.J., Feldman E.J., Davey F.R., Schiffer C.A., Larson R.A., Bloomfield C.D., Cancer, and Leukemia Group B. (CANLGB 8461). Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 100 (2002) 4325-4336
17. Mauritzson N., Albin M., Rylander L., Billström R., Ahlgren T., Mikoczy Z., Björk J., Strömberg U., Nilsson P.G., Mitelman F., Hagmar L., and Johansson B. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001. Leukemia 16 (2002) 2366-2378
18. Haidar M.A., Cao X.-b., Manshouri T., Chan L.L., Glassman A., Kantarjian H.M., Keating M.J., Beran M.S., and Albitar M. p16INK4A and p15INK4B gene deletions in primary leukemias. Blood 86 (1995) 311-315
19. Fegan C.D., White D., and Sweeney M. C-myc amplification, double minutes and homogenous staining regions in a case of AML. Br J Haematol 90 (1995) 486-488
20. Govberg I.J., Wolf J.L., and Cotter P.D. Trisomy 4 and double minutes in acute myeloid leukemia - further evidence that double minutes can occur as the primary cytogenetic abnormality. Cancer Genet Cytogenet 121 (2000) 212-215
21. Reddy K.S. Double minutes (dmin) and homogeneously staining regions (hsr in myeloid disorders: a new case suggesting that dmin form hsr in vivo. Cytogenet Genome Res 119 (2007) 53-59
22. Streubel B., Valent P., Jäger U., Edelhäuser M., Wandt H., Wagner T., Büchner T., Lechner K., and Fonatsch C. Amplification of the MLL gene on double minutes, a homogeneously staining region, and ring chromosomes in five patients with acute myeloid leukemia or myelodysplastic syndrome. Genes Chromosomes Cancer 27 (2000) 380-386
23. Valent A., Benard J., Clausse B., barrios M., Valteau-Couanet D., Terrier-Lacombe M.-J., Spengler B., and Bernheim A. In vivo elimination of acentric double minutes containing amplified MYCN from neuroblastoma tumor cells through the formation of micronuclei. Am J Pathol 158 (2001) 1579-1584